Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Equity Average (2016 - 2025)

Avanos Medical (AVNS) has disclosed Equity Average for 13 consecutive years, with $778.1 million as the latest value for Q4 2025.

  • Quarterly Equity Average fell 24.39% to $778.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $778.1 million through Dec 2025, down 24.39% year-over-year, with the annual reading at $803.3 million for FY2025, 22.19% down from the prior year.
  • Equity Average hit $778.1 million in Q4 2025 for Avanos Medical, up from $400000.0 in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $1.5 billion in Q1 2023 to a low of -$738.8 million in Q2 2025.
  • Historically, Equity Average has averaged $851.8 million across 5 years, with a median of $920.2 million in 2023.
  • Biggest five-year swings in Equity Average: soared 4661.68% in 2021 and later crashed 193.73% in 2025.
  • Year by year, Equity Average stood at $1.3 billion in 2021, then increased by 0.67% to $1.3 billion in 2022, then dropped by 3.77% to $1.2 billion in 2023, then fell by 16.28% to $1.0 billion in 2024, then dropped by 24.39% to $778.1 million in 2025.
  • Business Quant data shows Equity Average for AVNS at $778.1 million in Q4 2025, $400000.0 in Q3 2025, and -$738.8 million in Q2 2025.